Xcout IntelTizona Therapeutics
Tizona Therapeutics, Inc. is a privately held immunology company founded in 2015 and headquartered in South San Francisco, California. The company focuses on harnessing the power of the immune system to develop treatments.
Subscribe to see Tizona Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Tizona Therapeutics at a glance
Tizona Therapeutics is a biotechnology company headquartered in United States, founded in 2015. Its most recent funding round, Series B, raised $43M in March 2016. Xcout tracks 8 named people at Tizona Therapeutics, including Christine O Brien (Chief Executive Officer).
Tizona Therapeutics leadership
- Christine O BrienChief Executive Officer
- Courtney BeersChief Scientific Officer
- Robert Ilaria, Jr., MDChief Medical Officer
- Erin JohnsonSenior Vice President, Program Leadership and Alliance Management
- Dan SpiegelmanChair, Tizona Therapeutics Director, Myriad Genetics, Inc. Former EVP & CFO, BioMarin Pharmaceutical Inc.
- Kurt Von EmsterManaging Partner, Abingworth
2 more named people on record for Tizona Therapeutics, with roles, board committees and tenure — see the full roster →
Tizona Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $43M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Tizona Therapeutics competitors
A few of Tizona Therapeutics's closest competitors — see the full list of competitors and alternatives →
Ouro Medicines is a biotechnology company headquartered in South San Francisco, California, developing immune reset therapeutics for chronic immune-mediated diseases.
RAPT Therapeutics is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. Founded in 2015, the public company leverages its proprietary drug discovery platform to develop treatments for inflammatory and immunologic diseases.
TRex Bio, Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California. The company focuses on discovering and developing precision therapeutics to treat moderate-to-severe immune-mediated diseases by targeting regulatory T cells.
Sift Biosciences is a privately held biotechnology company founded in 2024 and headquartered in San Carlos, California. The company is focused on harnessing pre-existing hidden immunity.
Immune Design Corp. is a clinical-stage immunotherapy company with offices in Seattle, Washington, and South San Francisco, California, specializing in novel drug discovery and treatment technologies.
Dualitas Therapeutics is a privately held biotechnology research company headquartered in South San Francisco, California, that utilizes its DualScreen Bispecific Discovery Engine for proximity engagers.
Get Tizona Therapeutics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Tizona Therapeutics in Xcout Intel
- 8 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access